FR3006894B1 - Microparticules avec des cyclodextrines a double-niveaux d’encapsulation - Google Patents

Microparticules avec des cyclodextrines a double-niveaux d’encapsulation

Info

Publication number
FR3006894B1
FR3006894B1 FR1355520A FR1355520A FR3006894B1 FR 3006894 B1 FR3006894 B1 FR 3006894B1 FR 1355520 A FR1355520 A FR 1355520A FR 1355520 A FR1355520 A FR 1355520A FR 3006894 B1 FR3006894 B1 FR 3006894B1
Authority
FR
France
Prior art keywords
cyclodextrins
microparticles
double
encapsulation levels
encapsulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1355520A
Other languages
English (en)
Other versions
FR3006894A1 (fr
Inventor
Charlotte Delalande
Frederic Burtin
Yves Chevalier
Marie-Alexandrine Bolzinger
Jocelyne Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LCA DERMATECH, FR
Centre National de la Recherche Scientifique CNRS
Universite Claude Bernard Lyon 1 UCBL
Original Assignee
COSMETIQUE ALPINE AVANCEE
Centre National de la Recherche Scientifique CNRS
Universite Claude Bernard Lyon 1 UCBL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COSMETIQUE ALPINE AVANCEE, Centre National de la Recherche Scientifique CNRS, Universite Claude Bernard Lyon 1 UCBL filed Critical COSMETIQUE ALPINE AVANCEE
Priority to FR1355520A priority Critical patent/FR3006894B1/fr
Priority to EP14734895.7A priority patent/EP3007675A1/fr
Priority to PCT/FR2014/051474 priority patent/WO2014199105A1/fr
Priority to JP2016518575A priority patent/JP2016522218A/ja
Priority to US14/896,943 priority patent/US20160175229A1/en
Publication of FR3006894A1 publication Critical patent/FR3006894A1/fr
Application granted granted Critical
Publication of FR3006894B1 publication Critical patent/FR3006894B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A61K8/0287—Matrix particles the particulate containing a solid-in-solid dispersion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mathematical Physics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
FR1355520A 2013-06-14 2013-06-14 Microparticules avec des cyclodextrines a double-niveaux d’encapsulation Expired - Fee Related FR3006894B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1355520A FR3006894B1 (fr) 2013-06-14 2013-06-14 Microparticules avec des cyclodextrines a double-niveaux d’encapsulation
EP14734895.7A EP3007675A1 (fr) 2013-06-14 2014-06-16 Microparticules avec des cyclodextrines à double niveau d'encapsulation
PCT/FR2014/051474 WO2014199105A1 (fr) 2013-06-14 2014-06-16 Microparticules avec des cyclodextrines à double niveau d'encapsulation
JP2016518575A JP2016522218A (ja) 2013-06-14 2014-06-16 二段階の封入構造を有するシクロデキストリンを備えた微粒子
US14/896,943 US20160175229A1 (en) 2013-06-14 2014-06-16 Microparticles with cyclodextrins having a dual level of encapsulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1355520A FR3006894B1 (fr) 2013-06-14 2013-06-14 Microparticules avec des cyclodextrines a double-niveaux d’encapsulation

Publications (2)

Publication Number Publication Date
FR3006894A1 FR3006894A1 (fr) 2014-12-19
FR3006894B1 true FR3006894B1 (fr) 2015-09-11

Family

ID=49237327

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1355520A Expired - Fee Related FR3006894B1 (fr) 2013-06-14 2013-06-14 Microparticules avec des cyclodextrines a double-niveaux d’encapsulation

Country Status (5)

Country Link
US (1) US20160175229A1 (fr)
EP (1) EP3007675A1 (fr)
JP (1) JP2016522218A (fr)
FR (1) FR3006894B1 (fr)
WO (1) WO2014199105A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800004333A1 (it) * 2018-04-09 2019-10-09 Procedimento per il trattamento dei capelli
KR102333497B1 (ko) * 2019-12-31 2021-12-01 주식회사 마크로케어 메조포러스 실리카 복합체 및 이의 제조방법
KR102312284B1 (ko) * 2021-03-26 2021-10-13 주식회사 에코먼트 사이클로덱스트린-베타글루칸 복합 구조체 및 이를 포함하는 화장료 조성물
CN116473857B (zh) * 2023-04-03 2024-08-06 广东丸美生物技术股份有限公司 油芯凝珠、制备方法以及化妆品
EP4445898A1 (fr) * 2023-04-13 2024-10-16 Emoviar PharmaCon GmbH Formes posologiques à libération prolongée comprenant des complexes de composés à faible solubilité et procédés pour leur préparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429628A (en) * 1993-03-31 1995-07-04 The Procter & Gamble Company Articles containing small particle size cyclodextrin for odor control
US5861144A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Perfumed compositions for reducing body odors and excess moisture
US7452547B2 (en) * 2004-03-31 2008-11-18 Johnson&Johnson Consumer Co., Inc. Product for treating the skin comprising a polyamine microcapsule wall and a skin lightening agent
ES2747978T3 (es) * 2005-10-03 2020-03-12 Mark A Pinsky Liposomas no fosfolipídicos que comprenden ácido hialurónico
WO2009046116A1 (fr) * 2007-10-01 2009-04-09 Dennis Gross Produits de soin pour la peau contenant de multiples améliorateurs

Also Published As

Publication number Publication date
EP3007675A1 (fr) 2016-04-20
US20160175229A1 (en) 2016-06-23
WO2014199105A1 (fr) 2014-12-18
JP2016522218A (ja) 2016-07-28
FR3006894A1 (fr) 2014-12-19

Similar Documents

Publication Publication Date Title
FR3006466B3 (fr) .
UY4298S (es) Carcasa
DK3079750T3 (da) Udskyllelige katetre
EP2973170A4 (fr) Exécution d'un code de profilage
DK3022110T3 (da) Cykelsadel
DK3620198T3 (da) Udskyllelige katetre
DE112014003050A5 (de) Durchflussmessgerät
DK2996488T3 (da) Talloliefedtsyre
FR3006894B1 (fr) Microparticules avec des cyclodextrines a double-niveaux d’encapsulation
FR3001302B1 (fr) .
DK3080385T3 (da) Forbedret lukkeapparat
DK3012185T3 (da) Slæbebåd/bunkerbugserbåd-kombination
FR3010437B1 (fr) Serrure a mortaiser reglable
FR3008873B1 (fr) Siege releveur
DK3066223T4 (da) Heteropolysaccharider
FR3001303B1 (fr) .
FR3002558B1 (fr) Gabion avec rangees porteuses differentes
FR3008113B1 (fr) Gabion
TH1501001913B (th) แม่แบบการห่อหุ้ม
DK3071509T3 (da) En donkraft
UA27487S (uk) Пакет господарчий
UA29327S (uk) Велосипед
UA27662S (uk) Дитяче ліжко
UA28965S (uk) Велосипед
UA28717S (uk) Гойдалка

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: UNIVERSITE CLAUDE BERNARD, FR

Effective date: 20150120

Owner name: LCA-A DERMATECH, FR

Effective date: 20150120

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Effective date: 20150120

PLFP Fee payment

Year of fee payment: 3

CD Change of name or company name

Owner name: UNIVERSITE CLAUDE BERNARD, FR

Effective date: 20151112

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Effective date: 20151112

Owner name: LCA DERMATECH, FR

Effective date: 20151112

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20180228